N.S. company launching clinical trial to examine magic mushrooms as treatment for PTSD

CBC News | Oct. 24, 2022, 5 a.m. | Original

Halucenex Life Sciences Inc. in Windsor, N.S., is in the midst of the province's first clinical trial using the psychoactive substance psilocybin. Researchers hope to demonstrate the efficacy of the drug for treating post-traumatic stress disorder.

The Good Deeds Cup is on hold, but that's not stopping these hockey teams from a ruined N.L. community from he Rising heating oil costs push more low-income Nova Scotians to ask for help, says charity